Skip to main content
. 2012 Mar 7;2012:183983. doi: 10.5402/2012/183983

Figure 1.

Figure 1

Study design: in both groups, patients were called monthly to evaluated use of medications and clinical control of symptoms. Each 3 months a complete clinical evaluation was due. Immunotherapy injection was due each month.